Ronan T Swords
4PUBLICATIONS
74CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jun 25, 2025
A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years.Eric D Eisenmann, Ronan Swords, Ying Huang
|May 21, 2025
Genetic and Phenotypic Correlates of Clinical Outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN Study.Curtis A Lachowiez, Mael Heiblig, Gaspar Aspas Requena
|Sep 12, 2023
Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy.Christopher A Eide, Stephen E Kurtz, Andy Kaempf
|Jan 20, 2018
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML.Ronan T Swords, Steven Coutre, Michael B Maris
Pageof 1
Frequent Collaborators
3 joint publications
Joshua Zeidner
2 joint publications
Curtis A Lachowiez
2 joint publications
Brian J Druker
2 joint publications
Jennifer N Saultz
2 joint publications
Jeffrey W Tyner
2 joint publications
Anupriya Agarwal
2 joint publications
Stephen E Kurtz
2 joint publications
Andy Kaempf
2 joint publications
Nicola Long
2 joint publications
Christopher A Eide
